[The 2016 update of the S3 guideline for malignant tumours of the ovary : Role of pathology in diagnosis, therapy and clinical management of epithelial tumours].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28664411)

Published in Pathologe on June 29, 2017

Authors

A Staebler1, D Mayr2

Author Affiliations

1: Institut für Pathologie und Neuropathologie, Universität Tübingen, Liebermeisterstraße 8, 72074, Tübingen, Deutschland. annette.staebler@med.uni-tuebingen.de.
2: Pathologisches Institut, Ludwig-Maximilians-Universität München, München, Deutschland.

Articles cited by this

Fallopian tube precursors of ovarian low- and high-grade serous neoplasms. Histopathology (2013) 1.41

Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility study. Am J Surg Pathol (2011) 1.37

Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer. Clin Cancer Res (2013) 1.30

The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded. Am J Pathol (2016) 1.29

STICS, SCOUTs and p53 signatures; a new language for pelvic serous carcinogenesis. Front Biosci (Elite Ed) (2011) 1.23

Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinoma. Am J Surg Pathol (2007) 1.23

Gene expression profiling and prediction of clinical outcome in ovarian cancer. Crit Rev Oncol Hematol (2009) 1.13

CA-125 change after chemotherapy in prediction of treatment outcome among advanced mucinous and clear cell epithelial ovarian cancers: a Gynecologic Oncology Group study. Cancer (2009) 1.08

Chemosensitivity and chemoresistance testing in ovarian cancer. Curr Opin Obstet Gynecol (2009) 0.97

Moving toward personalized medicine: treatment-focused genetic testing of women newly diagnosed with ovarian cancer. Int J Gynecol Cancer (2010) 0.96

Immunology of gynecologic neoplasms: analysis of the prognostic significance of the immune status. Curr Cancer Drug Targets (2009) 0.90

Ovarian seromucinous carcinoma: report of a series of a newly categorized and uncommon neoplasm. Am J Surg Pathol (2015) 0.89

Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR). Mod Pathol (2015) 0.87

An Immunohistochemical Algorithm for Ovarian Carcinoma Typing. Int J Gynecol Pathol (2016) 0.84

Predicting the response of advanced cervical and ovarian tumors to therapy. Obstet Gynecol Surv (2009) 0.80